Relationship between hypertension, diabetes and proteinuria in rural and urban households in Yemen

Little information is available on the meanings of proteinuria in low-resource settings. A population-based, cross-sectional survey was performed in Yemen on 10 242 subjects aged 15–69 years, stratified by age, gender and urban/rural residency. Hypertension is defined as systolic blood pressure (BP) of ⩾140 mm Hg and/or diastolic BP of ⩾90 mm Hg, and/or self-reported use of antihypertensive drugs; diabetes is diagnosed as fasting glucose of ⩾126 mg dl−1 or self-reported use of hypoglycaemic medications; proteinuria is defined as ⩾+1 at dipstick urinalysis. Odds ratios (ORs) for associations were determined by multivariable logistic regression models. Prevalence (weighted to the Yemen population aged 15–69 years) of hypertension, diabetes and proteinuria were 7.5, 3.7 and 5.1% in urban, and 7.8, 2.6 and 7.3% in rural locations, respectively. Proteinuria and hypertension were more prevalent among rural dwellers (adjusted ORs 1.56; 95% confidence limit (Cl) 1.31–1.86, and 1.23; 1.08–1.41, respectively), diabetes being less prevalent in rural areas (0.70; 0.58–0.85). Differently from hypertension and diabetes, proteinuria was inversely related with age. Most importantly, 4.6 and 6.1% of urban and rural dwellers, respectively, had proteinuria in the absence of hypertension and diabetes. The approach of considering kidney damage as a consequence of hypertension and diabetes might limit the effectiveness of prevention strategies in low-income countries.

[1]  M. Woodward,et al.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis , 2012, The Lancet.

[2]  M. Mansournia,et al.  Social disparities in prevalence, treatment and control of hypertension in Iran: Second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006 , 2010, Journal of hypertension.

[3]  Rafael Lozano,et al.  AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD , 2000 .

[4]  G. Remuzzi,et al.  The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. , 2011, Kidney international.

[5]  J. Galvão,et al.  [Tuberculosis and the kidney]. , 1998, Acta medica portuguesa.

[6]  V. Jha,et al.  Nephropathy associated with animal, plant, and chemical toxins in the tropics. , 2003, Seminars in nephrology.

[7]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[8]  N. Bhamarapravati,et al.  Glomerular changes in acute plasmodium falciparum infection. An immunopathologic study. , 1973, Archives of pathology.

[9]  Ming Liu,et al.  Features of Acute Ischemic Stroke With Rheumatic Heart Disease in a Hospitalized Chinese Population , 2012, Stroke.

[10]  M. Woodward,et al.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis , 2012, The Lancet.

[11]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[12]  Jie Chen,et al.  [An epidemiological survey of atrial fibrillation in China]. , 2004, Zhonghua nei ke za zhi.

[13]  Valerie D. Glenn International Data Base (IDB) , 2013 .

[14]  A. Assabri,et al.  Prevalence of type 2 diabetes and other cardiovascular risk factors in a semirural area in Yemen. , 2008, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[15]  Nan Chen,et al.  Prevalence of chronic kidney disease in China: a cross-sectional survey , 2012, The Lancet.

[16]  G. Gensini,et al.  Impact of one or two visits strategy on hypertension burden estimation in HYDY, a population-based cross-sectional study: implications for healthcare resource allocation decision making , 2012, BMJ Open.

[17]  P. Modesti,et al.  Conventional dipsticks in the screening of microalbuminuria and urinary tract infections. Killing 2 birds with one stone? , 2010, Saudi medical journal.

[18]  H. Varmus,et al.  Accelerating progress on non-communicable diseases , 2013, The Lancet.

[19]  Gunaid Aa,et al.  Prevalence of type 2 diabetes and other cardiovascular risk factors in a semirural area in Yemen. , 2008 .

[20]  P. A. Modesti,et al.  The impact of fine-tuning of optical recognition system on database reliability , 2012, Comput. Biol. Medicine.

[21]  Yang Qiu,et al.  US Renal Data System 2010 Annual Data Report. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  Richard J. Johnson,et al.  Hygiene hypothesis and prevalence of glomerulonephritis. , 2005, Kidney international. Supplement.

[23]  J. Feehally Chronic kidney disease: Health burden of kidney disease recognized by UN , 2012, Nature Reviews Nephrology.

[24]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[25]  R. Barsoum Schistosomiasis and the kidney. , 2003, Seminars in nephrology.

[26]  M. Woodward,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension in China: Data from the China National Nutrition and Health Survey 2002 , 2008, Circulation.

[27]  N. Perico,et al.  Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA , 2012, BMJ Open.

[28]  A. A. Gunaid Prevalence of known diabetes and hypertension in the Republic of Yemen. , 2002, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[29]  Pietro Amedeo Modesti,et al.  Point-of-care testing of cholesterol and triglycerides for epidemiologic studies: evaluation of the multicare-in system. , 2009, Translational research : the journal of laboratory and clinical medicine.

[30]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[31]  K. Iseki,et al.  Proteinuria and the risk of developing end-stage renal disease. , 2003, Kidney international.

[32]  G. MacGregor,et al.  WASH-world action on salt and health. , 2010, Kidney international.

[33]  N. Perico,et al.  Chronic kidney disease: a research and public health priority. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[35]  Rachel Leach,et al.  Rethinking the “Diseases of Affluence” Paradigm: Global Patterns of Nutritional Risks in Relation to Economic Development , 2005, PLoS medicine.